Idexis (Pty) Ltd t/a Sentra Pharmacy and Another v Novo Nordisk (Pty) Ltd (130119/2024) [2025] ZAGPPHC 393 (8 April 2025)

Idexis (Pty) Ltd t/a Sentra Pharmacy and Another v Novo Nordisk (Pty) Ltd (130119/2024) [2025] ZAGPPHC 393 (8 April 2025)

The court found that the applicants' rule 35 notice was confusing, failed to comply with the requirements of the relevant subrules, and did not clearly specify the documents sought. The applicants did not serve a rule 30A notice nor properly seek condonation for non-compliance. The arguments advanced for exceptional...

Source-derived case information.

Citation
[2025] ZAGPPHC 393
Parties
Applicant: Idexis (Pty) Ltd t/a Sentra Pharmacy; Applicant: Dr Ruaan Louw; Respondent: Novo Nordisk (Pty) Ltd; Respondent: Adrian Botha SC; Respondent: Adv. Bongani Mazibuko
Court
North Gauteng High Court, Pretoria
Jurisdiction
South Africa
Judgment Date
8 April 2025
Case Number
130119/2024
Procedural Posture
Interlocutory Application / Application to Compel Discovery and for Directions on Discovery in Pending Main Application
Outcome
Application dismissed with costs on attorney-client scale.
Judges
Retief
Legal Topics
Discovery Procedure, Rule 35 Application, Interim Interdict, Abuse of Process
Civil Procedure Commercial and Corporate Discovery Procedure Rule 35 Application Interim Interdict Abuse of Process

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 5 Party arguments 2
Sign in to unlock

Parties

Idexis (Pty) Ltd t/a Sentra Pharmacy

Applicant

Dr Ruaan Louw

Applicant

Novo Nordisk (Pty) Ltd

Respondent

Adrian Botha SC

Respondent

Adv. Bongani Mazibuko

Respondent

Procedural Posture

Interlocutory Application / Application to Compel Discovery and for Directions on Discovery in Pending Main Application

Legal Issues

  1. 1 Whether the applicants are entitled to compel the respondent to deliver documents under rule 35(12), (13), (14), and (15).
  2. 2 Whether the applicants have complied with the procedural requirements of rule 30A before seeking relief.
  3. 3 Whether exceptional circumstances exist to justify general discovery in the interlocutory application.

Ratio Decidendi

The court found that the applicants' rule 35 notice was confusing, failed to comply with the requirements of the relevant subrules, and did not clearly specify the documents sought. The applicants did not serve a rule 30A notice nor properly seek condonation for non-compliance. The arguments advanced for exceptional circumstances were not supported by facts or relevant to the subject matter. The procedural defects and confusion caused by the applicants amounted to an abuse of process, and the application to compel discovery and for directions was dismissed. Costs were awarded against the applicants on the attorney-client scale due to their failure to comply with the rules and the...

Court Disposition

Application dismissed with costs on attorney-client scale.

Orders

  • The application is dismissed.
  • The First and Second Applicant, Idexis (Pty) Ltd t/a Sentra Pharmacy and Dr Ruaan Louw, are ordered to pay the Respondent, Novo Nordisk (Pty) Ltd, costs on an attorney client scale, such costs to include the costs of two Counsel, if so employed.